Jaipur, October, 2019. Medlife, India’s largest e-health company in India with three business lines including pharmacy, diagnostics and e-consultation, is witnessing an increasing traction for cardiac medicines from Tier 2 cities.The customer-centric brand is offering a flat 20% discount on cardiac medicines. Medlife sources genuine healthcare products from authorized dealers at discounted prices and has grown to become a trusted brand over the years.

The other medicines in demand include those for diabetes, dermatological,respiratory, and gynecological conditions. Medlife has a steadfast conviction of offering drugs only against a valid doctor’s prescription. The company also has a cashback and referral discount policy making it a go-to brand for all kinds of medicines even in Tier 2 cities like Jaipur.Medlife has a 30% share of the e-pharmacy market, which is expected to reach 50% in the next 2 to 3 years. There has been 2X increase in the demand QoQ for Medlife’s services in Jaipur, which is the 9^th largest city for the company.

Speaking about this, Meera Iyer, Chief Marketing Officer, Medlife said, “Medlife is rapidly expanding its footprint in many Tier 2 cities in India, becoming their preferred partner for medicines and other health essentials. We have been experiencing a high demand from cities such as Jaipur. Customers form the core of all our initiatives, and we are happy that we have been able to help improve the quality of life for our themby delivering medicines in a timely manner. We see this as a fulfilment of Medlife’s larger goal of making healthcare accessible and affordable for all.”

Medlife currently services over 20,000 deliveries across 29 states and 25,000 pin codes across 22 Indian states. The company recently crossed the 1000 crore-plus run rate as of March 2019. The company expects to achieve overall sales of 1500 crore with an exit run rate of 2000 crore over the next financial year. Medlife has one national and five regional laboratories and over 350 phlebotomists helping bring diagnostics to patients’ homes. It has also launched its e-consultation service after acquiring Eclinic247 last year.